Unstable angina non ST elevation myocardial infarction natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
Line 43: Line 43:
===Prognosis of Unstable Angina Pectoris===
===Prognosis of Unstable Angina Pectoris===
In unstable angina adverse events tend to occur early after admission and can be predicted by clinical and EKG characteristics.  The greater the magnitude and duration of EKG changes, the poorer the prognosis.  ST depression on EKG at admission and the presence of transient ischemia predicted an increased risk of MI and subsequent death whereas normal EKG patterns are associated with a good outcome.  1 year MI or death rate in patients with new ST deviation (more than 1 mm from baseline) has been shown to be 11% compared to 6.8% in patients with isolated [[T-wave inversion]].  The most powerful predictors of [[MI]] and [[death]] include history of [[hypertension]] and presence of transient ischemia.  Similarly persistence of pain is also associated with an unfavorable outcome.
In unstable angina adverse events tend to occur early after admission and can be predicted by clinical and EKG characteristics.  The greater the magnitude and duration of EKG changes, the poorer the prognosis.  ST depression on EKG at admission and the presence of transient ischemia predicted an increased risk of MI and subsequent death whereas normal EKG patterns are associated with a good outcome.  1 year MI or death rate in patients with new ST deviation (more than 1 mm from baseline) has been shown to be 11% compared to 6.8% in patients with isolated [[T-wave inversion]].  The most powerful predictors of [[MI]] and [[death]] include history of [[hypertension]] and presence of transient ischemia.  Similarly persistence of pain is also associated with an unfavorable outcome.
Significant determinants of poor outcome include:
* Congestive heart failure
* Hypotension
* New or worsening mitral regurgitation
* Sustained Ventricular tachycardia
* Poor ejection fraction
* Refractory angina


===Prognosis in NSTEMI ===
===Prognosis in NSTEMI ===

Revision as of 21:55, 2 December 2012

Acute Coronary Syndrome Main Page

Unstable angina / NSTEMI Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Unstable Angina
Non-ST Elevation Myocardial Infarction

Differentiating Unstable Angina/Non-ST Elevation Myocardial Infarction from other Disorders

Epidemiology and Demographics

Risk Stratification

Natural History, Complications and Prognosis

Special Groups

Women
Heart Failure and Cardiogenic Shock
Perioperative NSTE-ACS Related to Noncardiac Surgery
Stress (Takotsubo) Cardiomyopathy
Diabetes Mellitus
Post CABG Patients
Older Adults
Chronic Kidney Disease
Angiographically Normal Coronary Arteries
Variant (Prinzmetal's) Angina
Substance Abuse
Cardiovascular "Syndrome X"

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Blood Studies
Biomarkers

Electrocardiogram

Chest X Ray

Echocardiography

Coronary Angiography

Treatment

Primary Prevention

Immediate Management

Anti-Ischemic and Analgesic Therapy

Cholesterol Management

Antitplatelet Therapy

Antiplatelet therapy recommendations
Aspirin
Thienopyridines
Glycoprotein IIb/IIIa Inhibitor

Anticoagulant Therapy

Additional Management Considerations for Antiplatelet and Anticoagulant Therapy

Risk Stratification Before Discharge for Patients With an Ischemia-Guided Strategy of NSTE-ACS

Mechanical Reperfusion

Initial Conservative Versus Initial Invasive Strategies
PCI
CABG

Complications of Bleeding and Transfusion

Discharge Care

Medical Regimen
Post-Discharge Follow-Up
Cardiac Rehabilitation

Long-Term Medical Therapy and Secondary Prevention

ICD implantation within 40 days of myocardial infarction

ICD within 90 days of revascularization

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Unstable angina non ST elevation myocardial infarction natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Unstable angina non ST elevation myocardial infarction natural history, complications and prognosis

CDC onUnstable angina non ST elevation myocardial infarction natural history, complications and prognosis

Unstable angina non ST elevation myocardial infarction natural history, complications and prognosis in the news

Blogs on Unstable angina non ST elevation myocardial infarction natural history, complications and prognosis

to Hospitals Treating Unstable angina non ST elevation myocardial infarction natural history, complications and prognosis

Risk calculators and risk factors for Unstable angina non ST elevation myocardial infarction natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

Unstable angina / NSTEMI are signs of more severe heart disease. Natural history is complicated by the development of arrhythmias and heart failure. In a study it was shown that 14% of the cases of unstable angina can progress to MI. Sudden death is an infrequent sequel of both UA and NSTEMI.

Complications

Unstable angina

The incidence of ischemic complications and the risk of death in unstable angina pectoris is lower than that of patients with either non ST elevation myocardial infarction (NSTEMI) or that or patients with ST segment elevation myocardial infarction (STEMI) but higher than that of patients with chronic stable angina pectoris. Unstable angina can lead to:

List of factors that may effect the development and complications of NSTEMI

(In alphabetical order)

  • Blood lipid levels
  • Catecholamine levels (smoking, cocaine, stress)
  • Degree of coronary vasoconstriction
  • Endothelial function
  • Extent of collaterals
  • Extent of plaque rupture or erosion
  • Inflammatory substrate
  • Location of the culprit coronary lesion
  • Microembolization and microvascular obstruction
  • Stenosis morphology and severity
  • Systemic factors
  • Thrombotic factors
  • Blood viscosity
  • Intrinsic clotting activity
  • Leukocyte activation
  • Level of fibrinolytic activity
  • Plaque tissue factor levels
  • Platelet aggregability and reactivity

Prognosis

Prognosis of Unstable Angina Pectoris

In unstable angina adverse events tend to occur early after admission and can be predicted by clinical and EKG characteristics. The greater the magnitude and duration of EKG changes, the poorer the prognosis. ST depression on EKG at admission and the presence of transient ischemia predicted an increased risk of MI and subsequent death whereas normal EKG patterns are associated with a good outcome. 1 year MI or death rate in patients with new ST deviation (more than 1 mm from baseline) has been shown to be 11% compared to 6.8% in patients with isolated T-wave inversion. The most powerful predictors of MI and death include history of hypertension and presence of transient ischemia. Similarly persistence of pain is also associated with an unfavorable outcome. Significant determinants of poor outcome include:

  • Congestive heart failure
  • Hypotension
  • New or worsening mitral regurgitation
  • Sustained Ventricular tachycardia
  • Poor ejection fraction
  • Refractory angina

Prognosis in NSTEMI

Cardiac Troponin I is a very sensitive marker of degree of myocardial damage and provides a prognostic value in patients with NSTEMI.

Related Chapters

Sources

  • The ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction [1]

References

  1. Anderson JL, Adams CD, Antman EM; et al. (2007). "ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine". JACC. 50 (7): e1–e157. PMID 17692738. Text "doi:10.1016/j.jacc.2007.02.013 " ignored (help); Unknown parameter |month= ignored (help)

Template:WH Template:WS